| Transplantation |
0 |
0.75 |
| Transplant Registry |
0 |
0.53 |
| Liver |
0 |
0.49 |
| Biliary Disease |
0 |
0.45 |
| Liver Disease |
0 |
0.44 |
| End-Stage Liver Disease |
0 |
0.4 |
| Aminotransferase |
0 |
0.38 |
| Liver Biopsy |
0 |
0.38 |
| Model for End-Stage Liver Disease (MELD) |
0 |
0.36 |
| Graft Survival |
0 |
0.3 |
| Graft |
0 |
0.29 |
| Autoimmune Hepatitis |
0 |
0.21 |
| Hepatitis |
0 |
0.16 |
| Hepatitis A |
0 |
0.16 |
| Immunoglobulin G (IgG) |
0 |
0.16 |
| Biopsy |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Immunocompromise |
0 |
0.1 |
| Protocol Biopsy |
0 |
0.09 |
| Cyclosporine |
0 |
0.07 |
| Organ Procurement and Transplantation Network |
0 |
0.05 |
| Acute Rejection |
0 |
0.03 |
| Adherence |
0 |
0.03 |
| Autoimmune Disease |
0 |
0.03 |
| Biomarker |
0 |
0.03 |
| Cholangitis |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Immunosuppressive Therapy |
0 |
0.03 |